| Item Type | Name |
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Mass Screening
|
|
Concept
|
Drug Screening Assays, Antitumor
|
|
Academic Article
|
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
|
|
Academic Article
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
|
|
Academic Article
|
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.
|
|
Academic Article
|
New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer.
|
|
Academic Article
|
A Population-Based Study of Genes Previously Implicated in Breast Cancer.
|
|
Academic Article
|
Individualized-thresholding Shear Wave Elastography combined with clinical factors improves specificity in discriminating breast masses.
|
|
Academic Article
|
Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML.
|
|
Academic Article
|
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.
|
|
Academic Article
|
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort.
|
|
Academic Article
|
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
|
|
Academic Article
|
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
|
|
Academic Article
|
Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up.
|
|
Academic Article
|
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression.
|
|
Academic Article
|
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis.
|
|
Academic Article
|
Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance.
|
|
Academic Article
|
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.
|
|
Academic Article
|
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
|
|
Academic Article
|
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.
|
|
Academic Article
|
Assessment of MRI-detected lesions on screening tomosynthesis in patients with newly diagnosed breast cancer.
|
|
Academic Article
|
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
|
|
Academic Article
|
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
|
|
Academic Article
|
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
|
|
Academic Article
|
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity.
|
|
Academic Article
|
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel.
|
|
Academic Article
|
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort.
|
|
Academic Article
|
Association of ?H2AX at Diagnosis with Chemotherapy Outcome in Patients with Breast Cancer.
|
|
Academic Article
|
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.
|
|
Academic Article
|
Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer.
|
|
Academic Article
|
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
|
|
Academic Article
|
Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers.
|
|
Academic Article
|
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.
|
|
Academic Article
|
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.
|
|
Academic Article
|
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.
|
|
Academic Article
|
Quantitative Biomarkers for Cancer Detection Using Contrast-Free Ultrasound High-Definition Microvessel Imaging: Fractal Dimension, Murray's Deviation, Bifurcation Angle & Spatial Vascularity Pattern.
|
|
Academic Article
|
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.
|
|
Academic Article
|
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
|
|
Academic Article
|
Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracy.
|
|
Academic Article
|
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
|
|
Academic Article
|
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2.
|
|
Academic Article
|
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
|
|
Concept
|
Triple Negative Breast Neoplasms
|
|
Academic Article
|
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
|
|
Academic Article
|
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
|
|
Academic Article
|
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain.
|